<< CSR 1975-2010 Home

The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 32.9

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 25-29

Both Sexes
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 39,117 55.1 0.7* 11,637 60.0 1.3*
1. Leukemias 1,662 2.3 0.1 506 2.6 1.3*
2. Lymphomas 5,900 8.3 0.7 1,637 8.4 0.9
3. CNS, intracranial, intraspinal 2,020 2.8 0.9* 608 3.1 0.9*
4. Osseous & chondromatous nepolasms 475 0.7 1.1* 143 0.7 1.1*
5. Soft tissue sarcomas 2,973 4.2 1.7 574 3.0 1.1
6. Germ cell and trophoblastic neoplasms 4,965 7.0 1.4* 1,526 7.9 2.2*
7. Melanoma and skin carcinomas 5,395 7.6 1.2* 1,759 9.1 1.2*
8. Carcinomas (excluding skin) 15,177 21.4 0.4* 4,713 24.3 1.4*
9. Miscellaneous specified neoplasms, NOS 359 0.5 1.6* 125 0.6 1.6*
10. Unspecified malignant neoplasms 191 0.3 - 46 0.2 -
Males
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 17,712 49.7 0.9* 5,078 52.1 1.6*
1. Leukemias 967 2.7 -0.1 281 2.9 1.3*
2. Lymphomas 3,363 9.4 0.9 887 9.1 1.9
3. CNS, intracranial, intraspinal 1,105 3.1 0.9* 333 3.4 0.9*
4. Osseous & chondromatous nepolasms 273 0.8 0.2 71 0.7 0.2
5. Soft tissue sarcomas 2,192 6.1 2.1 383 3.9 0.3
6. Germ cell and trophoblastic neoplasms 4,582 12.8 1.4* 1,438 14.7 0.7*
7. Melanoma and skin carcinomas 1,923 5.4 0.2 550 5.6 0.2
8. Carcinomas (excluding skin) 3,083 8.6 0.3 1,054 10.8 1.9*
9. Miscellaneous specified neoplasms, NOS 140 0.4 - 55 0.6 -
10. Unspecified malignant neoplasms 84 0.2 - 26 0.3 -
Females
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 21,405 60.5 0.6* 6,559 68.1 1.0*
1. Leukemias 695 2.0 1.0* 225 2.3 1.0*
2. Lymphomas 2,537 7.2 0.8* 750 7.8 0.8*
3. CNS, intracranial, intraspinal 915 2.6 0.8* 275 2.9 0.8*
4. Osseous & chondromatous nepolasms 202 0.6 1.8* 72 0.7 1.8*
5. Soft tissue sarcomas 781 2.2 0.7 191 2.0 -1.5
6. Germ cell and trophoblastic neoplasms 383 1.1 -1.2* 88 0.9 -1.2*
7. Melanoma and skin carcinomas 3,472 9.8 1.7* 1,209 12.6 1.7*
8. Carcinomas (excluding skin) 12,094 34.2 0.4 3,659 38.0 1.2*
9. Miscellaneous specified neoplasms, NOS 219 0.6 0.5 70 0.7 0.5
10. Unspecified malignant neoplasms 107 0.3 - 20 0.2 -

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2010.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.